KR20080097019A - New fourth group transition metal compounds having hetero atom - Google Patents
New fourth group transition metal compounds having hetero atom Download PDFInfo
- Publication number
- KR20080097019A KR20080097019A KR1020070042084A KR20070042084A KR20080097019A KR 20080097019 A KR20080097019 A KR 20080097019A KR 1020070042084 A KR1020070042084 A KR 1020070042084A KR 20070042084 A KR20070042084 A KR 20070042084A KR 20080097019 A KR20080097019 A KR 20080097019A
- Authority
- KR
- South Korea
- Prior art keywords
- radical
- group
- formula
- carbon atoms
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/28—Titanium compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/42—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
- C08F4/44—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
- C08F4/60—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
- C08F4/62—Refractory metals or compounds thereof
- C08F4/64—Titanium, zirconium, hafnium or compounds thereof
- C08F4/642—Component covered by group C08F4/64 with an organo-aluminium compound
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/42—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
- C08F4/72—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from metals not provided for in group C08F4/44
- C08F4/74—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from metals not provided for in group C08F4/44 selected from refractory metals
- C08F4/76—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from metals not provided for in group C08F4/44 selected from refractory metals selected from titanium, zirconium, hafnium, vanadium, niobium or tantalum
Abstract
Description
본 발명은 헤테로 원자를 포함하는 사이클로펜타다이에닐 리간드가 배위된 새로운 전이금속 화합물 및 이의 제조방법에 관한 것이다.The present invention relates to a novel transition metal compound coordinated with a cyclopentadienyl ligand comprising a hetero atom and a method for preparing the same.
주기율표 15족 또는 16족의 헤테로 원자인 질소, 인, 산소, 또는 황 등을 포함하는 메탈로센 화합물은 많은 예가 보고되고 있다.Many examples have been reported of metallocene compounds including nitrogen, phosphorus, oxygen, sulfur, and the like, which are heteroatoms of group 15 or 16 of the periodic table.
일반적으로 이러한 헤테로 원자를 포함하는 메탈로센 화합물은 크게 두 가지 그룹으로 나눌 수 있다.In general, the metallocene compound containing such a hetero atom can be roughly divided into two groups.
첫 번째 그룹은 헤테로사이클로펜타다이에닐기, 또는 헤테로 원자를 포함하는 고리를 사이클로펜타다이에닐기 또는 그 유도체와 융합한 형태의 리간드 구조를 갖는 메탈로센 화합물이다.The first group is a metallocene compound having a ligand structure in which a heterocyclopentadienyl group or a ring containing a hetero atom is fused with a cyclopentadienyl group or a derivative thereof.
WO 95/04087는 주기율표 15족 헤테로 원자를 포함하는 헤테로사이클로펜타다이에닐 메탈로센 화합물을 기재하고 있다. 이 외에도 질소 원자를 포함하는 사이클로펜타다이에닐기를 갖는 아자페로센(azaferrocene) 화합물에 관한 예도 보고되고 있다(A. P. Sadomenko et al. Cood. Chem. Rev., 1993, 126, 237).WO 95/04087 describes heterocyclopentadienyl metallocene compounds comprising a Group 15 hetero atom of the periodic table. In addition, examples of azaferrocene compounds having a cyclopentadienyl group containing a nitrogen atom have been reported (A. P. Sadomenko et al. Cood. Chem. Rev., 1993, 126, 237).
헤테로사이클이 융합된 사이클로펜타다이에닐 또는 그 유도체 형태의 리간드 구조를 갖는 메탈로센 화합물 역시 많은 예가 알려져 있다. 이러한 구조의 화합물은 전통적인 메탈로센 화합물인 비스사이클로펜타다이에닐 형태와 사이클로펜타다이에닐기를 브릿지로 연결하는 ansa-형태의 메탈로센 화합물을 모두 포함한다(WO 98/22486, WO 01/48039, US 6,451,938, WO 03/04551, Gregory C. Fu et al. J. Org. Chem., 1996, 61, 7230).Many examples are also known of metallocene compounds having a ligand structure in the form of a cyclopentadienyl or derivative thereof in which a heterocycle is fused. Compounds of this structure include both biscyclopentadienyl forms, which are traditional metallocene compounds, and ansa-type metallocene compounds that link cyclopentadienyl groups (WO 98/22486, WO 01 /). 48039, US 6,451,938, WO 03/04551, Gregory C. Fu et al. J. Org.Chem., 1996, 61, 7230.
두 번째 그룹은 다이알킬아민과 같은 기능기가 부가적인 사슬로서 사이클로펜타다이에닐기과 연결된 구조의 메탈로센 화합물이다(P. Jutzi et al. J. Organomet. Chem., 1995, 486, 287., P. Jutzi et al. Organometallics, 1996, 4153., P. Jutzi et al. J. Organomet. Chem., 1997, 538, 163., P. Jutzi et al. Eur. J. Inorg. Chem., 1998, 663).The second group is a metallocene compound of a structure in which a functional group such as dialkylamine is connected with a cyclopentadienyl group as an additional chain (P. Jutzi et al. J. Organomet. Chem., 1995, 486, 287., P. Jutzi et al. Organometallics, 1996, 4153., P. Jutzi et al. J. Organomet. Chem., 1997, 538, 163., P. Jutzi et al. Eur. J. Inorg.Chem., 1998, 663).
WO 2004/005305는 피페리딘(piperidine)과 같은 고리 형태의 알킬아민 기능기가 도입된 티타늄(lV) 메탈로센 화합물의 합성을 기재하고 있다.WO 2004/005305 describes the synthesis of titanium (lV) metallocene compounds in which alkylamine functional groups in the form of rings, such as piperidine, are introduced.
본 발명은 헤테로 원자를 포함하는 사이클로펜타다이에닐 리간드가 배위된 새로운 전이금속 화합물을 제공하고자 한다.The present invention seeks to provide a novel transition metal compound coordinated with a cyclopentadienyl ligand comprising a hetero atom.
또한, 본 발명은 상기 전이금속 화합물의 제조방법을 제공하고자 한다.In addition, the present invention is to provide a method for producing the transition metal compound.
본 발명은 상기 목적을 달성하기 위하여, 하기 화학식 1로 표시되는 새로운 전이금속 화합물을 제공한다.The present invention provides a novel transition metal compound represented by the following formula (1) to achieve the above object.
상기 화학식 1에서,In Chemical Formula 1,
X1 및 X2는 서로 동일하거나 상이하고, 각각 독립적으로 할로겐 라디칼, 탄소수 1 내지 20의 알킬 라디칼, 아릴 라디칼, 알킬아릴 라디칼, 아릴알킬 라디칼, 알킬 아미노 라디칼, 아릴 아미노 라디칼, 또는 탄소수 1 내지 20의 알킬리덴 라디칼이며;X 1 and X 2 are the same as or different from each other, and each independently a halogen radical, an alkyl radical having 1 to 20 carbon atoms, an aryl radical, an alkylaryl radical, an arylalkyl radical, an alkyl amino radical, an aryl amino radical, or an alkyl having 1 to 20 carbon atoms. A leaden radical;
M은 주기율표 4족 전이금속이고;M is a periodic table Group 4 transition metal;
Cp1 및 Cp2는 서로 동일하거나 상이하고, 각각 독립적으로 사이클로펜타다이에닐기; 인데닐기; 플루오레닐기; 또는 히드로카빌, 알킬, 아릴, 실릴, 할로겐, 및 할로히드로카빌 중 하나 이상의 치환기로 치환된 사이클로펜타다이에닐 유도체로, 에타-5(η-5) 형태로 중심금속 M에 배위하며, 2개 이상의 치환기는 서로 연결되어 지방족 또는 방향족 고리를 형성할 수 있으며; Cp1 and Cp2 are the same as or different from each other, and each independently a cyclopentadienyl group; Indenyl group; Fluorenyl group; Or a cyclopentadienyl derivative substituted with one or more substituents of hydrocarbyl, alkyl, aryl, silyl, halogen, and halohydrocarbyl, coordinated to central metal M in the form of eta-5 (η-5), two The above substituents may be linked to each other to form an aliphatic or aromatic ring;
CY1은 지방족 또는 방향족 고리이며;CY1 is an aliphatic or aromatic ring;
Y1은 주기율표 15족 또는 16족의 헤테로 원자이며;Y 1 is a hetero atom of group 15 or 16 of the periodic table;
R2는 탄소수 1 내지 20의 알킬 라디칼, 아릴 라디칼, 알킬아릴 라디칼 또는 아릴알킬 라디칼이며, R2는 Y1이 주기율표 16족의 헤테로 원자일 경우 존재하지 않으며;R 2 is an alkyl radical having 1 to 20 carbon atoms, an aryl radical, an alkylaryl radical or an arylalkyl radical, and R 2 is absent when Y 1 is a hetero atom of Group 16 of the periodic table;
R1, R1' 및 R1"은 서로 동일하거나 상이하고, 각각 독립적으로 수소, 할로겐 라디칼, 탄소수 1 내지 20의 알킬 라디칼, 아릴 라디칼, 알콕시 라디칼, 아릴옥시 라디칼, 또는 아미노 라디칼이며, R1, R1' 및 R1" 중 적어도 2개는 서로 연결되어 지방족 또는 방향족 고리를 형성할 수 있다.R1, R1 'and R1 "are the same as or different from each other, and are each independently hydrogen, a halogen radical, an alkyl radical having 1 to 20 carbon atoms, an aryl radical, an alkoxy radical, an aryloxy radical, or an amino radical, and R1, R1' and At least two of R 1 ″ may be linked to each other to form an aliphatic or aromatic ring.
또한, 본 발명은 하기 화학식 2로 표시되는 새로운 전이금속 화합물을 제공한다.The present invention also provides a novel transition metal compound represented by the following formula (2).
상기 화학식 2에서,In Chemical Formula 2,
X1 및 X2는 서로 동일하거나 상이하고, 각각 독립적으로 할로겐 라디칼, 탄소수 1 내지 20의 알킬 라디칼, 아릴 라디칼, 알킬아릴 라디칼, 아릴알킬 라디칼, 알킬 아미노 라디칼, 아릴 아미노 라디칼, 또는 탄소수 1 내지 20의 알킬리덴 라디칼이며;X 1 and X 2 are the same as or different from each other, and each independently a halogen radical, an alkyl radical having 1 to 20 carbon atoms, an aryl radical, an alkylaryl radical, an arylalkyl radical, an alkyl amino radical, an aryl amino radical, or an alkyl having 1 to 20 carbon atoms. A leaden radical;
M은 주기율표 4족 전이금속이고;M is a periodic table Group 4 transition metal;
Cp1 및 Cp2는 서로 동일하거나 상이하고, 각각 독립적으로 사이클로펜타다이에닐기; 인데닐기; 플루오레닐기; 또는 히드로카빌, 알킬, 아릴, 실릴, 할로겐, 및 할로히드로카빌 중 하나 이상의 치환기로 치환된 사이클로펜타다이에닐 유도체로, 에타-5(η-5) 형태로 중심금속 M에 배위하며, 2개 이상의 치환기는 서로 연결되어 지방족 또는 방향족 고리를 형성할 수 있으며;Cp1 and Cp2 are the same as or different from each other, and each independently a cyclopentadienyl group; Indenyl group; Fluorenyl group; Or a cyclopentadienyl derivative substituted with one or more substituents of hydrocarbyl, alkyl, aryl, silyl, halogen, and halohydrocarbyl, coordinated to central metal M in the form of eta-5 (η-5), two The above substituents may be linked to each other to form an aliphatic or aromatic ring;
CY1 및 CY2는 서로 동일하거나 상이하고, 각각 독립적으로 지방족 또는 방향족 고리이며;CY1 and CY2 are the same as or different from each other, and each independently an aliphatic or aromatic ring;
Y1 및 Y2는 서로 동일하거나 상이하고, 각각 독립적으로 주기율표 15족 또는 16족의 헤테로 원자이며;Y1 and Y2 are the same as or different from each other, and each independently a hetero atom of group 15 or 16 of the periodic table;
R2 및 R4은 서로 동일하거나 상이하고, 각각 독립적으로 탄소수 1 내지 20의 알킬 라디칼, 아릴 라디칼, 알킬아릴 라디칼 또는 아릴알킬 라디칼이며, R2 또는 R4는 Y1 또는 Y2가 주기율표 16족의 헤테로 원자일 경우 존재하지 않으며;R2 and R4 are the same as or different from each other, and each independently an alkyl radical, aryl radical, alkylaryl radical or arylalkyl radical having 1 to 20 carbon atoms, and R2 or R4 is present when Y1 or Y2 is a hetero atom of group 16 of the periodic table. Not;
R1, R1', R1", R3, R3' 및 R3"는 서로 동일하거나 상이하고, 각각 독립적으로 수소, 할로겐 라디칼, 탄소수 1 내지 20의 알킬 라디칼, 아릴 라디칼, 알콕시 라디칼, 아릴옥시 라디칼, 또는 아미노 라디칼이며, R1, R1', 및 R1" 중 적어도 2개, 또는 R3, R3' 및 R3" 중 적어도 2개는 서로 연결되어 지방족 또는 방향족 고리를 형성할 수 있다.R1, R1 ', R1 ", R3, R3' and R3" are the same as or different from each other, and each independently hydrogen, a halogen radical, an alkyl radical having 1 to 20 carbon atoms, an aryl radical, an alkoxy radical, an aryloxy radical, or amino It is a radical and at least two of R1, R1 ', and R1 ", or at least two of R3, R3', and R3" may be linked to each other to form an aliphatic or aromatic ring.
또한, 본 발명은 하기 화학식 3으로 표시되는 유기 화합물을 제공한다.In addition, the present invention provides an organic compound represented by the following formula (3).
상기 화학식 3에서, In Chemical Formula 3,
R1, R1', R1", R2, CY1, 및 Y1은 상기 화학식 1에서의 정의와 동일하고;R1, R1 ', R1 ", R2, CY1, and Y1 are the same as the definition in Formula 1 above;
R5, R6, R7, 및 R8은 서로 같거나 상이하고, 각각 독립적으로 수소 원자; 탄소수 1 내지 20의 알킬 라디칼; 탄소수 2 내지 20의 알케닐 라디칼; 실릴 라디칼; 알킬아릴 라디칼; 또는 아릴알킬 라디칼이며; 상기 R5 내지 R8은 탄소수 1 내지 20의 알킬 또는 아릴 라디칼을 포함하는 알킬리딘 라디칼에 의해 서로 연결되어 고리를 형성할 수 있다.R5, R6, R7, and R8 are the same as or different from each other, and each independently a hydrogen atom; Alkyl radicals having 1 to 20 carbon atoms; Alkenyl radicals having 2 to 20 carbon atoms; Silyl radicals; Alkylaryl radicals; Or an arylalkyl radical; The R5 to R8 may be connected to each other by an alkylidine radical including an alkyl or aryl radical having 1 to 20 carbon atoms to form a ring.
이하 상기 화학식의 각 치환기들에 대해 구체적으로 설명한다.Hereinafter, each substituent of the above formula will be described in detail.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 할로겐 라디칼은 플루오린기, 염소기, 브롬기 또는 요오드기를 의미한다.In Chemical Formulas 1, 2, and 3, a halogen radical means a fluorine group, a chlorine group, a bromine group, or an iodine group.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 탄소수 1 내지 20의 알킬 라디칼은 직쇄 또는 분지쇄의 알킬 라디칼을 포함한다.In Formula 1, Formula 2, and Formula 3, the alkyl radical having 1 to 20 carbon atoms includes a linear or branched alkyl radical.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 아릴 라디칼은 탄소수 1 내지 20 인 것이 바람직하며, 구체적으로는 페닐, 나프틸, 안트라세닐, 피리딜, 디메틸아닐리닐, 아니솔릴 등이 있으나, 이들에만 한정되는 것은 아니다.In Formula 1, Formula 2, and Formula 3, the aryl radical is preferably 1 to 20 carbon atoms, specifically, phenyl, naphthyl, anthracenyl, pyridyl, dimethylanilinyl, anisolyl, and the like. It is not limited.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 알킬아릴 라디칼은 상기 알킬 라디칼에 의하여 치환된 아릴 라디칼을 의미한다.In Formula 1, Formula 2, and Formula 3, an alkylaryl radical means an aryl radical substituted by the alkyl radical.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 아릴알킬 라디칼은 상기 아릴 라디칼에 의하여 치환된 알킬 라디칼을 의미한다.In Formula 1, Formula 2, and Formula 3, an arylalkyl radical means an alkyl radical substituted by the aryl radical.
상기 화학식 1 및 화학식 2에서, 알킬 아미노 라디칼은 상기 알킬 라디칼에 의하여 치환된 아미노 라디칼을 의미하며, 디메틸아미노기, 디에틸아미노기 등이 있으나, 이들예로만 한정된 것은 아니다.In Formula 1 and Formula 2, an alkyl amino radical means an amino radical substituted by the alkyl radical, and there are dimethylamino group, diethylamino group, and the like, but is not limited thereto.
상기 화학식 1 및 화학식 2에서, 아릴 아미노 라디칼은 상기 아릴 라디칼에 의하여 치환된 아미노 라디칼을 의미하며, 구체적으로는 디페닐아미노기 등이 있으나, 이에만 한정되는 것은 아니다.In Formula 1 and Formula 2, the aryl amino radical means an amino radical substituted by the aryl radical, and specifically, there are diphenylamino groups and the like, but is not limited thereto.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 실릴 라디칼은 트리메틸실릴, 트리에틸실릴, 트리프로필실릴, 트리부틸실릴, 트리헥실실릴, 트리이소프로필실릴, 트리이소부틸실릴, 트리에톡시실릴, 트리페닐실릴, 트리스(트리메틸실릴)실릴 등이 있으나, 이들에만 한정되는 것은 아니다.In Formula 1, Formula 2, and Formula 3, the silyl radical is trimethylsilyl, triethylsilyl, tripropylsilyl, tributylsilyl, trihexylsilyl, triisopropylsilyl, triisobutylsilyl, triethoxysilyl, tri Phenylsilyl, tris (trimethylsilyl) silyl, and the like, but are not limited thereto.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 15족 원소로는 N, P 등이 있으나, 이들에만 한정되는 것은 아니다.In Chemical Formulas 1, 2, and 3, Group 15 elements include N, P, and the like, but are not limited thereto.
상기 화학식 1, 화학식 2, 및 화학식 3에서, 16족 원소로는 O, S 등이 있으나, 이들에만 한정되는 것은 아니다.In Chemical Formula 1, Chemical Formula 2, and Chemical Formula 3, Group 16 elements include O and S, but are not limited thereto.
상기 화학식 1 및 화학식 2에서, 4족 전이금속으로는 Ti, Zr, Hf 등이 있다.In Formula 1 and Formula 2, Group 4 transition metals include Ti, Zr, Hf, and the like.
본 발명의 상기 화학식 1 또는 화학식 2의 전이금속 화합물은 헤테로 원자를 포함하는 사이클로펜타다이에닐 리간드가 배위된 것을 특징으로 하는 전이금속 화합물이다.The transition metal compound of Formula 1 or Formula 2 of the present invention is a transition metal compound characterized in that a cyclopentadienyl ligand comprising a hetero atom is coordinated.
본 발명에 따른 상기 화학식 1 또는 화학식 2로 표시되는 전이금속 화합물, 및 상기 화학식 3으로 표시되는 유기 화합물의 제조방법은 후술하는 실시예에 상세히 기재되어 있다.The transition metal compound represented by Chemical Formula 1 or Chemical Formula 2 according to the present invention, and a method of preparing the organic compound represented by Chemical Formula 3 are described in detail in the following examples.
또한, 본 발명은 상기 화학식 1 또는 화학식 2의 전이금속 화합물을 포함하는 촉매 조성물을 제공한다.In addition, the present invention provides a catalyst composition comprising the transition metal compound of Formula 1 or Formula 2.
상기 촉매 조성물은 상기 화학식 1의 화합물 이외에 하기 화학식 4 내지 6으로 표시되는 화합물들 중 1종 이상의 조촉매 화합물을 포함할 수 있다.The catalyst composition may include at least one cocatalyst compound of the compounds represented by the following Chemical Formulas 4 to 6 in addition to the compound of Chemical Formula 1.
상기 화학식 4에서,In Chemical Formula 4,
R9는 서로 동일하거나 다를 수 있으며, 각각 독립적으로 할로겐기, 탄소수 1 내지 20의 탄화수소기, 또는 할로겐으로 치환된 탄소수 1 내지 20의 탄화수소기이고, n은 2 이상의 정수이다.R9 may be the same or different from each other, and each independently represent a halogen group, a hydrocarbon group having 1 to 20 carbon atoms, or a hydrocarbon group having 1 to 20 carbon atoms substituted with halogen, and n is an integer of 2 or more.
상기 화학식 5에서,In Chemical Formula 5,
R9는 상기 화학식 4에서 정의된 바와 같고,R9 is as defined in Formula 4,
D는 알루미늄 또는 보론이다.D is aluminum or boron.
상기 화학식 6에서,In Chemical Formula 6,
L은 중성 또는 양이온성 루이스 산이고,L is a neutral or cationic Lewis acid,
H는 수소 원자이며,H is a hydrogen atom,
Z는 13족 원소이고,Z is a group 13 element,
A는 서로 동일하거나 다를 수 있으며, 각각 독립적으로 1 이상의 수소 원자가 할로겐기, 탄소수 1 내지 20의 탄화수소기, 알콕시 또는 페녹시로 치환 또는 비치환된 탄소수 6 내지 20의 아릴 또는 탄소수 1 내지 20의 알킬이다.A may be the same or different from each other, and each independently one or more hydrogen atoms are substituted with a halogen group, a hydrocarbon group having 1 to 20 carbon atoms, alkoxy or phenoxy, or an aryl having 6 to 20 carbon atoms or an alkyl having 1 to 20 carbon atoms. to be.
상기 화학식 4로 표시되는 화합물의 예로는 메틸알루미녹산, 에틸알루미녹산, 이소부틸알루미녹산, 부틸알루미녹산 등이 있으며, 더욱 바람직한 화합물은 메틸알루미녹산이다.Examples of the compound represented by the formula (4) include methyl aluminoxane, ethyl aluminoxane, isobutyl aluminoxane, butyl aluminoxane and the like, and more preferred compound is methyl aluminoxane.
상기 화학식 5로 표시되는 화합물의 예로는 트리메틸알루미늄, 트리에틸알루미늄, 트리이소부틸알루미늄, 트리프로필알루미늄, 트리부틸알루미늄, 디메틸클로로알루미늄, 트리이소프로필알루미늄, 트리-s-부틸알루미늄, 트리사이클로펜틸알루미늄, 트리펜틸알루미늄, 트리이소펜틸알루미늄, 트리헥실알루미늄, 트리옥틸알루 미늄, 에틸디메틸알루미늄, 메틸디에틸알루미늄, 트리페닐알루미늄, 트리-p-톨릴알루미늄, 디메틸알루미늄메톡시드, 디메틸알루미늄에톡시드, 트리메틸보론, 트리에틸보론, 트리이소부틸보론, 트리프로필보론, 트리부틸보론 등이 포함되며, 더욱 바람직한 화합물은 트리메틸알루미늄, 트리에틸알루미늄, 트리이소부틸알루미늄 중에서 선택된다.Examples of the compound represented by Formula 5 include trimethyl aluminum, triethyl aluminum, triisobutyl aluminum, tripropyl aluminum, tributyl aluminum, dimethylchloro aluminum, triisopropyl aluminum, tri-s-butyl aluminum, tricyclopentyl aluminum , Tripentyl aluminum, triisopentyl aluminum, trihexyl aluminum, trioctyl aluminum, ethyl dimethyl aluminum, methyl diethyl aluminum, triphenyl aluminum, tri-p-tolyl aluminum, dimethyl aluminum methoxide, dimethyl aluminum ethoxide, Trimethylboron, triethylboron, triisobutylboron, tripropylboron, tributylboron and the like, and more preferred compounds are selected from trimethylaluminum, triethylaluminum and triisobutylaluminum.
상기 화학식 6으로 표시되는 화합물의 예로는 트리에틸암모니움테트라페닐보론, 트리부틸암모니움테트라페닐보론, 트리메틸암모니움테트라페닐보론, 트리프로필암모니움테트라페닐보론, 트리메틸암모니움테트라(p-톨릴)보론, 트리메틸암모니움테트라(o,p-디메틸페닐)보론, 트리부틸암모니움테트라(p-트리폴로로메틸페닐)보론, 트리메틸암모니움테트라(p-트리플로로메틸페닐)보론, 트리부틸암모니움테트라펜타플로로페닐보론, N,N-디에틸아밀리디움테트라페닐보론, N,N-디에틸아닐리디움테트라페닐보론, N,N-디에틸아닐리니움테트라펜타플로로페닐보론, 디에틸암모니움테트라펜타플로로페닐보론, 트리페닐포스포늄테트라페닐보론, 트리메틸포스포늄테트라페닐보론, 트리에틸암모니움테트라페닐알루미늄, 트리부틸암모니움테트라페닐알루미늄, 트리메틸암모니움테트라페닐알루미늄, 트리프로필암모니움테트라페닐알루미늄, 트리메틸암모니움테트라(p-톨릴)알루미늄, 트리프로필암모니움테트라(p-톨릴)알루미늄, 트리에틸암모니움테트라(o,p-디메틸페닐)알루미늄, 트리부틸암모니움테트라(p-트리플로로메틸페닐)알루미늄, 트리메틸암모니움테트라(p-트리플로로메틸페닐)알루미늄, 트리부틸암모니움테트라펜타플로로페닐알루미늄, N,N-디에틸아닐리니움테트라페닐알루미늄, N,N-디에틸아닐리니움테트라페닐알루미늄, N,N-디에틸아 닐리니움테트라펜타플로로페닐알루미늄, 디에틸암모니움테트라펜타텐트라페닐알루미늄, 트리페닐포스포늄테트라페닐알루미늄, 트리메틸포스포늄테트라페닐알루미늄, 트리에틸암모니움테트라페닐알루미늄, 트리부틸암모니움테트라페닐알루미늄, 트리메틸암모니움테트라페닐보론, 트리프로필암모니움테트라페닐보론, 트리메틸암모니움테트라(p-톨릴)보론,트리프로필암모니움테트라(p-톨릴)보론, 트리에틸암모니움테트라(o,p-디메틸페닐)보론, 트리메틸암모니움테트라(o,p-디메틸페닐)보론, 트리부틸암모니움테트라(p-트리플로로메틸페닐)보론, 트리메틸암모니움테트라(p-트리플로로메틸페닐)보론, 트리부틸암모니움테트라펜타플로로페닐보론, N,N-디에틸아닐리니움테트라페닐보론, N,N-디에틸아닐리니움테트라페닐보론, N,N-디에틸아닐리니움테트라펜타플로로페닐보론, 디에틸암모니움테트라펜타플로로페닐보론, 트리페닐포스포늄테트라페닐보론, 트리페닐카보니움테트라(p-트리풀로로메틸페닐)보론, 트리페닐카보니움테트라펜타플로로페닐보론 등이 있다.Examples of the compound represented by Formula 6 include triethylammonium tetraphenylboron, tributylammonium tetraphenylboron, trimethylammonium tetraphenylboron, tripropylammonium tetraphenylboron, trimethylammonium tetra (p-tolyl) Boron, trimethylammonium tetra (o, p-dimethylphenyl) boron, tributylammonium tetra (p-tripololomethylphenyl) boron, trimethylammonium tetra (p-trifluoromethylphenyl) boron, tributylammonium tetra Pentafluorophenylboron, N, N-diethylamidiumdium tetraphenylboron, N, N-diethylanilidedium tetraphenylboron, N, N-diethylanilinium tetrapentafluorophenylboron, diethyl Ammonium tetrapentafluorophenyl boron, triphenyl phosphonium tetraphenyl boron, trimethyl phosphonium tetraphenyl boron, triethyl ammonium tetraphenyl aluminum, tributyl ammonium tetraphenyl aluminum, Limethyl ammonium tetraphenyl aluminum, tripropyl ammonium tetraphenyl aluminum, trimethyl ammonium tetra (p-tolyl) aluminum, tripropyl ammonium tetra (p-tolyl) aluminum, triethylammonium tetra (o, p-dimethyl Phenyl) aluminum, tributylammonium tetra (p-trifluoromethylphenyl) aluminum, trimethylammonium tetra (p-trifluoromethylphenyl) aluminum, tributylammonium tetrapentafluorophenylaluminum, N, N-diethyl Anilineum tetraphenylaluminum, N, N-diethylanilinium tetraphenylaluminum, N, N-diethylanilinium tetrapentafluorophenylaluminum, diethylammonium tetrapentatentraphenylaluminum, triphenylforce Phosphorus tetraphenyl aluminum, trimethyl phosphonium tetraphenyl aluminum, triethyl ammonium tetraphenyl aluminum, tributyl ammonium tetraphenyl aluminum, trimethyl ammonium Umtetraphenylboron, tripropylammonium tetraphenylboron, trimethylammonium tetra (p-tolyl) boron, tripropylammonium tetra (p-tolyl) boron, triethylammonium tetra (o, p-dimethylphenyl) boron , Trimethyl ammonium tetra (o, p-dimethylphenyl) boron, tributyl ammonium tetra (p-trifluoromethylphenyl) boron, trimethyl ammonium tetra (p-trifluoromethylphenyl) boron, tributyl ammonium tetrapenta Florophenylboron, N, N-diethylanilinium tetraphenylboron, N, N-diethylanilinium tetraphenylboron, N, N-diethylanilinium tetrapentafluorophenylboron, diethylammonium Um tetrapentafluorophenyl boron, a triphenyl phosphonium tetraphenyl boron, a triphenyl carbonium tetra (p-tripulomethyl phenyl) boron, a triphenyl carbonium tetra pentafluoro phenyl boron, etc. are mentioned.
상기 촉매 조성물은 1) 상기 화학식 1의 4족 전이금속 화합물과 상기 화학식 4 또는 화학식 5로 표시되는 화합물을 접촉시켜 혼합물을 얻는 단계; 및 2) 상기 혼합물에 상기 화학식 6으로 표시되는 화합물을 첨가하는 단계를 포함하는 방법으로 제조될 수 있다. 또한, 상기 촉매 조성물은 상기 화학식 1의 4족 전이금속 화합물과 상기 화학식 4로 표시되는 화합물을 접촉시키는 방법으로 제조될 수 있다.The catalyst composition comprises the steps of: 1) contacting the Group 4 transition metal compound of Formula 1 with the compound represented by Formula 4 or Formula 5 to obtain a mixture; And 2) it may be prepared by a method comprising the step of adding a compound represented by the formula (6) to the mixture. In addition, the catalyst composition may be prepared by a method of bringing the Group 4 transition metal compound of Formula 1 into contact with the compound represented by Formula 4.
상기 화학식 1 및 화학식 2의 4족 전이금속 화합물을 포함하는 촉매 조성물의 제조시에 반응 용매로서 펜탄, 헥산, 헵탄 등과 같은 탄화수소계 용매, 또는 벤젠, 톨루엔 등과 같은 방향족계 용매가 사용될 수 있다. 또한, 전이금속 화합물과 조촉매는 실리카나 알루미나에 담지된 형태로도 이용할 수 있다.Hydrocarbon solvents such as pentane, hexane, heptane, or the like, or aromatic solvents such as benzene, toluene, or the like may be used as a reaction solvent in preparing the catalyst composition including the Group 4 transition metal compounds of Formula 1 and Formula 2. In addition, the transition metal compound and the cocatalyst may be used in a form supported on silica or alumina.
이하의 실시예를 통하여 본 발명을 더욱 상세하게 설명한다. 단, 하기의 실시예는 본 발명을 예시하기 위한 것일 뿐 이들만으로 본 발명의 범위를 한정하는 것은 아니다.The present invention will be described in more detail with reference to the following examples. However, the following examples are only for illustrating the present invention and do not limit the scope of the present invention by only these.
<< 실시예Example >>
<< 리간드Ligand 및 전이금속 화합물의 합성> And synthesis of transition metal compounds>
유기 시약 및 용매는 알드리치(Aldrich)사와 머크(Merck)사에서 구입하여 표준 방법으로 정제하여 사용하였다. 합성의 모든 단계에서 공기와 수분의 접촉을 차단하여 실험의 재현성을 높였다. 화합물의 구조를 입증하기 위해 400MHz 핵자기 공명기(NMR)를 이용하여 스펙트럼을 얻었다.Organic reagents and solvents were purchased from Aldrich and Merck and purified using standard methods. At all stages of the synthesis, the contact between air and moisture was blocked to increase the reproducibility of the experiment. Spectra were obtained using a 400 MHz nuclear magnetic resonator (NMR) to demonstrate the structure of the compound.
[반응식 1]Scheme 1
<< 실시예Example 1> 1>
<< 실시예Example 1-1> 리튬 1-1> lithium 카바메이트Carbamate (( LithiumLithium carbamatecarbamate ) (2)) (2)
1,2,3,4-테트라하이드로퀴놀린(13.08g, 98.24mmol)과 다이에틸에테르(150mL)를 플라스크에 넣었다. 드라이아이스와 아세톤으로 만든 -78oC 저온조에 플라스크를 담가 30분간 교반한 후, 노말부틸리튬(39.3mL, 2.5M 헥산 용액, 98.24mmol)을 질소 분위기 하에 주사기로 투입하였다. 연한 노란색의 슬러리가 형성되었다. 2시간 동안 교반한 후에, 형성된 부탄 가스를 제거하면서 상온으로 올렸다. 플라스크를 다시 -78oC 저온조에 담가 온도를 낮춘 후 CO2 가스를 투입하였다. 이산화탄소 가스를 투입함에 따라 슬러리가 없어지면서 투명한 용액이 되었다. 플라스크를 버블러에 연결하여 이산화탄소 가스를 제거하면서 온도를 상온으로 올린 후에 진공을 걸어 여분의 CO2 가스와 용매를 제거하였다. 드라이박스로 플라스크를 옮긴 후 펜탄을 가하고 교반한 후 여과하여 흰색 고체 화합물을 얻었다. 상기 화합물은 다이에틸에테르가 배위결합 되어 있는 화합물이다. 이때 수율은 100% 이었다.1,2,3,4-tetrahydroquinoline (13.08 g, 98.24 mmol) and diethyl ether (150 mL) were placed in a flask. The flask was immersed in a -78 ° C. low temperature bath made of dry ice and acetone, stirred for 30 minutes, and then normal butyllithium (39.3 mL, 2.5 M hexane solution, 98.24 mmol) was introduced into a syringe under a nitrogen atmosphere. A light yellow slurry formed. After stirring for 2 hours, it was raised to room temperature while removing the butane gas formed. The flask was again immersed in a -78 o C low temperature bath to lower the temperature and CO 2 gas was added. As the carbon dioxide gas was added, the slurry disappeared and became a transparent solution. After the flask and connected to a bubbler to remove the carbon dioxide gas to raise the temperature to ambient temperature the vacuum walk extra CO 2 The gas and solvent were removed. The flask was transferred to a dry box, pentane was added thereto, stirred and filtered to obtain a white solid compound. The compound is a compound in which diethyl ether is coordinated. At this time, the yield was 100%.
1H NMR(C6D6, C5D5N) : δ 8.35(d, J=8.4Hz, 1H, CH), δ 6.93-6.81(m, 2H, CH), δ 6.64(t, J=7.4Hz, 1H, CH), δ 3.87 (br, s, 2H, quin-CH2), δ 3.25 (q, J = 7.2 Hz, 4H, ether), δ 2.34 (br s, 2H, quin-CH2), δ 1.50 (br s, 2H, quin-CH2), δ 1.90 (t, J = 7.2 Hz, 6H, ether) ppm. 1 H NMR (C 6 D 6 , C 5 D 5 N): δ 8.35 (d, J = 8.4 Hz, 1H, CH), δ 6.93-6.81 (m, 2H, CH), δ 6.64 (t, J = 7.4 Hz, 1 H, CH), δ 3.87 (br, s, 2H, quin-CH 2 ), δ 3.25 (q, J = 7.2 Hz, 4H, ether), δ 2.34 (br s, 2H, quin-CH 2 ), δ 1.50 (br s, 2H, quin-CH 2 ), δ 1.90 (t, J = 7.2 Hz, 6H, ether) ppm.
<< 실시예Example 1-2> 8-(2,3,4,5- 1-2> 8- (2,3,4,5- 테트라메틸Tetramethyl -1,3--1,3- 사이클로펜타다이에닐Cyclopentadienyl )-1,2,3,4-) -1,2,3,4- 테트라하이드로퀴놀린Tetrahydroquinoline (8-(2,3,4,5-(8- (2,3,4,5- TetramethylTetramethyl -1,3--1,3- cyclopentadienylcyclopentadienyl )-1,2,3,4-) -1,2,3,4- tetrahydroquinolinetetrahydroquinoline ))
리튬 카바메이트(2) 화합물(8.47g, 42.60mmol)을 플라스크에 넣었다. 테트라하이드로퓨란(4.6g, 63.9mmol)과 다이에틸에테르 45mL를 차례로 넣었다. 아세톤과 소량의 드라이아이스로 만든 -20oC 저온조에 플라스크를 담가 30분간 교반한 후, tert-BuLi(25.1mL, 1.7M, 42.60mmol)을 넣었다. 이 때 붉은색으로 변하였다. -20oC를 계속 유지하면서 6시간 동안 교반하였다. 테트라하이드로퓨란에 녹아있는 CeCl3·2LiCl 용액(129mL, 0.33M, 42.60mmol)과 테트라메틸사이클로펜티논(5.89g, 42.60mmol)을 주사기 안에서 섞어준 다음, 질소 분위기 하에서 플라스크로 투입하였다. 온도를 상온으로 천천히 올리다가 1시간 후에 항온조를 치워 온도를 상온으로 올렸다. 물(15mL)을 첨가한 후, 에틸 아세테이트를 넣어서 여과해서 여액을 얻었다. 그 여액을 분별 깔때기에 옮긴 후에 염산(2N, 80mL)을 넣어서 12분간 흔들어주었다. 그리고, 포화된 탄산수소나트륨 수용액(160mL)을 넣어서 중화한 후에 유기층을 추출해내었다. 이 유기층에 무수황산마그네슘을 넣어 수분을 제거하고 여과한 후, 그 여액을 취하고 용매를 제거하였다. 컬럼 크로마토그래피로 노란색 오일을 얻었다. 헥산 : 톨루엔(v/v, 10 : 1), 헥산 : 에틸아세테이트(v/v, 10 : 1), 수율은 40% 이었다.A lithium carbamate (2) compound (8.47 g, 42.60 mmol) was placed in the flask. Tetrahydrofuran (4.6 g, 63.9 mmol) and 45 mL of diethyl ether were added sequentially. The flask was immersed in a -20 o C low temperature bath made of acetone and a small amount of dry ice, stirred for 30 minutes, and then tert- BuLi (25.1 mL, 1.7 M, 42.60 mmol) was added thereto. At this time, it turned red. Stir for 6 hours while maintaining -20 o C. CeCl 3 · 2LiCl solution (129 mL, 0.33 M, 42.60 mmol) dissolved in tetrahydrofuran and tetramethylcyclopentinone (5.89 g, 42.60 mmol) were mixed in a syringe and then introduced into a flask under a nitrogen atmosphere. After slowly raising the temperature to room temperature, the thermostat was removed after 1 hour to raise the temperature to room temperature. After addition of water (15 mL), ethyl acetate was added and filtered to obtain a filtrate. The filtrate was transferred to a separatory funnel, and hydrochloric acid (2N, 80 mL) was added thereto, followed by shaking for 12 minutes. After neutralizing with saturated aqueous sodium hydrogen carbonate solution (160 mL), the organic layer was extracted. Anhydrous magnesium sulfate was added to this organic layer to remove water and filtered, and the filtrate was taken out and the solvent was removed. Column chromatography gave a yellow oil. Hexane: toluene (v / v, 10: 1), hexane: ethyl acetate (v / v, 10: 1), yield was 40%.
1H NMR(C6D6) : δ 1.00 (br d, 3H, Cp-CH3), 1.63 - 1.73 (m, 2H, quin-CH2), 1.80 (s, 3H, Cp-CH3), 1.81 (s, 3H, Cp-CH3), 1.85 (s, 3H, Cp-CH3), 2.64 (t, J = 6.0 Hz, 2H, quin-CH2), 2.84 - 2.90 (br, 2H, quin-CH2), 3.06 (br s, 1H, Cp-H), 3.76 (br s, 1H, N-H), 6.77 (t, J = 7.2 Hz, 1H, quin-CH), 6.92 (d, J = 2.4 Hz, 1H, quin-CH), 6.94 (d, J = 2.4 Hz, 1H, quin-CH) ppm. 1 H NMR (C 6 D 6 ): δ 1.00 (br d, 3H, Cp-CH 3 ), 1.63-1.73 (m, 2H, quin-CH 2 ), 1.80 (s, 3H, Cp-CH 3 ), 1.81 (s, 3H, Cp-CH 3 ), 1.85 (s, 3H, Cp-CH 3 ), 2.64 (t, J = 6.0 Hz, 2H, quin-CH 2 ), 2.84-2.90 (br, 2H, quin -CH 2 ), 3.06 (br s, 1H, Cp-H), 3.76 (br s, 1H, NH), 6.77 (t, J = 7.2 Hz, 1H, quin-CH), 6.92 (d, J = 2.4 Hz, 1H, quin-CH), 6.94 (d, J = 2.4 Hz, 1H, quin-CH) ppm.
<< 실시예Example 1-3> 리튬 1-(1- 1-3> lithium 1- (1- 메틸methyl -2,3,4--2,3,4- 트리하이드로퀴놀린Trihydroquinoline -8-일)-2,3,4,5-테트라메틸사이클로펜타다이에나이드(-8-yl) -2,3,4,5-tetramethylcyclopentadienide ( LithiumLithium 1-(1- 1- (1- methylmethyl -2,3,4--2,3,4- trihydroquinolintrihydroquinolin -8--8- ylyl )-2,3,4,5-) -2,3,4,5- tetramethylcyclopentadienidetetramethylcyclopentadienide ))
8-(2,3,4,5-테트라메틸-1,3-사이클로펜타다이에닐)-1,2,3,4-테트라하이드로퀴놀린(2g, 7.89mmol)을 메탄올(42mL)에 녹인 용액에 포름알데히드 37% 수용액(0.88mL, 11.8mmol)을 넣고, 상온에서 30분간 교반하였다. 이 혼합물에 디카보레인(decaborane, 0.29g, 2.37mmol)을 넣고 상온에서 1시간 동안 더 교반하였다. 생성된 화합물을 헥산 및 에틸 아세테이트(v : v = 10 : 1) 용매를 사용하여 실리카 패드에 여과하였다. 여과한 용액의 용매를 제거하여 얻은 화합물을 플라스크에 옮기고, 펜탄(50mL)을 넣은 후 온도를 -78oC로 낮추었다. -78oC에서 노말부틸리튬(3.2mL, 2.5M 헥산 용액, 7.89mmol)을 질소 분위기 하에 주사기로 투입하였다. 상온으로 천천히 승온한 후에 상온에서 3시간 동안 더 교반하였다. 반응물을 질소 분위기 하에서 거르고, 펜탄(10mL)으로 2번 세척한 후 진공 하에서 건조하였다. 노 란색 고체의 리튬염을 얻었다(0.837g, 39%).8- (2,3,4,5-tetramethyl-1,3-cyclopentadienyl) -1,2,3,4-tetrahydroquinoline (2 g, 7.89 mmol) in methanol (42 mL) Into a formaldehyde 37% aqueous solution (0.88 mL, 11.8 mmol) was added and stirred at room temperature for 30 minutes. Dicaborane (decaborane, 0.29 g, 2.37 mmol) was added to the mixture, followed by further stirring at room temperature for 1 hour. The resulting compound was filtered through a silica pad using hexane and ethyl acetate (v: v = 10: 1) solvent. The compound obtained by removing the solvent of the filtered solution was transferred to a flask, pentane (50 mL) was added, and the temperature was lowered to -78 ° C. Normal butyllithium (3.2 mL, 2.5 M hexane solution, 7.89 mmol) at −78 ° C. was introduced by syringe under nitrogen atmosphere. After slowly warming to room temperature, the mixture was further stirred at room temperature for 3 hours. The reaction was filtered under nitrogen atmosphere, washed twice with pentane (10 mL) and dried under vacuum. A yellow salt of a lithium salt was obtained (0.837 g, 39%).
1H NMR (pyr-d5): δ 7.31(br s, 1H, CH), δ 7.10-6.90(m, 1H, CH), δ 6.96(s, 1H, CH), δ 3.09(m, 2H, quinoline-CH2), δ 2.77 (t, J=6Hz, 2H, quinoline-CH2), δ 2.51-2.11(m, 15H, Cp-CH3, N-CH3), δ 1.76 (m, 2H, quinoline-CH2) ppm. 1 H NMR (pyr-d5): δ 7.31 (br s, 1H, CH), δ 7.10-6.90 (m, 1H, CH), δ 6.96 (s, 1H, CH), δ 3.09 (m, 2H, quinoline -CH 2 ), δ 2.77 (t, J = 6 Hz, 2H, quinoline-CH 2 ), δ 2.51-2.11 (m, 15H, Cp-CH 3 , N-CH 3 ), δ 1.76 (m, 2H, quinoline -CH 2 ) ppm.
<< 실시예Example 1-4> 비스[1-(1- 1-4> Bis [1- (1- 메틸methyl -2,3,4--2,3,4- 트리하이드로퀴놀린Trihydroquinoline -8-일)-2,3,4,5--8-day) -2,3,4,5- 테트라메틸사이클로펜타다이에닐Tetramethylcyclopentadienyl ]티타늄(Ⅳ) 디메틸 화합물] Titanium (IV) Dimethyl Compound
드라이박스 안에서 TiCl4·DME(429mg, 1.53mmol)와 다이에틸에테르(25mL)을 플라스크에 넣고 -30℃에서 교반하면서 MeLi(1.9mL, 1.6M 다이에틸에테르 용액, 3.07mmol)을 천천히 넣었다. 15분 동안 교반한 후에 상기 실시예 1-3에서 얻은 리튬염 화합물(838mg, 3.06mmol)을 플라스크에 넣었다. 온도를 상온으로 올리면서 3시간 동안 교반하였다. 반응이 끝난 후, 진공을 걸어 용매를 제거하고, 펜탄에 녹여서 여과해서 여액을 추출하였다. 진공을 걸어 펜탄을 제거하고 티타늄 화합물(titanium complex)을 얻었다.In a dry box, TiCl 4 DME (429 mg, 1.53 mmol) and diethyl ether (25 mL) were added to a flask, and MeLi (1.9 mL, 1.6 M diethyl ether solution, 3.07 mmol) was slowly added thereto while stirring at -30 ° C. After stirring for 15 minutes, the lithium salt compound (838 mg, 3.06 mmol) obtained in Example 1-3 was placed in a flask. Stir for 3 hours while raising the temperature to room temperature. After the reaction was completed, vacuum was applied to remove the solvent, dissolved in pentane, filtered, and the filtrate was extracted. Vacuum to remove pentane and titanium compounds ( titanium complex).
1H NMR(C6D6) : δ 6.83(d, J=7.2Hz, 2H, CH), δ 6.78(d, J=7.6Hz, 2H, CH), δ 6.73(t, J=7.4Hz, 2H, CH), δ 2.80(m, 4H, quin-CH2), δ 2.52(t, J=6.4Hz, 4H, quin-CH2), δ 2.26(s, 6H, N-CH3), δ 1.96(s, 12H, Cp-CH3), δ 1.85(s, 12H, Cp- CH3), δ 1.50(m, 4H, quin-CH2), δ 1.26(s, 6H, Ti-CH3) ppm. 1 H NMR (C 6 D 6 ): δ 6.83 (d, J = 7.2 Hz, 2H, CH), δ 6.78 (d, J = 7.6 Hz, 2H, CH), δ 6.73 (t, J = 7.4 Hz, 2H, CH), δ 2.80 (m, 4H, quin-CH 2 ), δ 2.52 (t, J = 6.4 Hz, 4H, quin-CH 2 ), δ 2.26 (s, 6H, N-CH 3 ), δ 1.96 (s, 12H, Cp-CH 3 ), δ 1.85 (s, 12H, Cp-CH 3 ), δ 1.50 (m, 4H, quin-CH 2 ), δ 1.26 (s, 6H, Ti-CH 3 ) ppm.
<< 실시예Example 2> 2>
<< 실시예Example 2-1> 6- 2-1> 6- 메틸methyl -8-(2,3,4,5--8- (2,3,4,5- 테트라메틸Tetramethyl -1,3--1,3- 시클로펜타디에닐Cyclopentadienyl )-1,2,3,4-테) -1,2,3,4-te 트라히드Trahid 로퀴놀린Loquinoline
6-메틸-1,2,3,4-테트라히드로퀴놀린을 사용하여 상기 실시예 1과 동일한 방법으로 리튬 카바메이트 화합물 및 6-메틸-8-(2,3,4,5-테트라메틸-1,3-시클로펜타디에닐)-1,2,3,4-테트라히드로퀴놀린을 제조하였다. 수율은 34% 이었다.Lithium carbamate compound and 6-methyl-8- (2,3,4,5-tetramethyl-1 in the same manner as in Example 1 using 6-methyl-1,2,3,4-tetrahydroquinoline , 3-cyclopentadienyl) -1,2,3,4-tetrahydroquinoline was prepared. The yield was 34%.
1H NMR(CDCl3): δ 6.70(s, 1H, CH), δ 6.54(s, 1H, CH), δ 3.71(br s, 1H, NH), δ 3.25-3.05(m, 3H, Cp-CH, quinoline-CH2), δ 2.76(t, J=6.4Hz, 2H, quinoline-CH2), δ 2.19(s, 3H, CH3), δ 1.93-1.86(m, 2H, quinoline-CH2), δ 1.88(s, 3H, Cp-CH3), δ 1.84(s, 3H, Cp-CH3), δ 1.74(s, 3H, Cp-CH3), δ 0.94(br d, J=6.8Hz, 3H, Cp-CH3) ppm. 1 H NMR (CDCl 3 ): δ 6.70 (s, 1H, CH), δ 6.54 (s, 1H, CH), δ 3.71 (br s, 1H, NH), δ 3.25-3.05 (m, 3H, Cp− CH, quinoline-CH 2 ), δ 2.76 (t, J = 6.4 Hz, 2H, quinoline-CH 2 ), δ 2.19 (s, 3H, CH 3 ), δ 1.93-1.86 (m, 2H, quinoline-CH 2 ), δ 1.88 (s, 3H, Cp-CH 3 ), δ 1.84 (s, 3H, Cp-CH 3 ), δ 1.74 (s, 3H, Cp-CH 3 ), δ 0.94 (br d, J = 6.8 Hz, 3H, Cp-CH 3 ) ppm.
<< 실시예Example 2-2> 리튬 1-(6,N-디메틸-1,2,3,4- 2-2> lithium 1- (6, N-dimethyl-1,2,3,4- 테트라히드로퀴놀린Tetrahydroquinoline -8-일)-2,3,4,5-테-8-day) -2,3,4,5-te 트라메틸시클로펜타다이Tramethylcyclopentadi 에나이드Enaid
6-메틸-8-(2,3,4,5-테트라메틸-1,3-시클로펜타디에닐)-1,2,3,4-테트라히드로퀴놀린을 사용하여 상기 실시예 1과 동일한 방법으로 제조하였다.6-methyl-8- (2,3,4,5-tetramethyl-1,3-cyclopentadienyl) -1,2,3,4-tetrahydroquinoline in the same manner as in Example 1 above Prepared.
1H NMR (pyr-d5): δ 7.05(br s, 1H, CH), δ 6.73(s, 1H, CH), δ 6.96(s, 1H, CH), δ 3.08(m, 2H, quinoline-CH2), δ 2.76(t, J=6.4Hz, 2H, quinoline-CH2), δ 2.57-2.25(m, 18H, Cp-CH3, Ph-CH3, N-CH3), δ 1.76 (m, 2H, quinoline-CH2) ppm. 1 H NMR (pyr-d5): δ 7.05 (br s, 1H, CH), δ 6.73 (s, 1H, CH), δ 6.96 (s, 1H, CH), δ 3.08 (m, 2H, quinoline-CH 2 ), δ 2.76 (t, J = 6.4 Hz, 2H, quinoline-CH 2 ), δ 2.57-2.25 (m, 18H, Cp-CH 3 , Ph-CH 3 , N-CH 3 ), δ 1.76 (m , 2H, quinoline-CH 2 ) ppm.
<< 실시예Example 2-3> 비스[1-(6,N-디메틸-1,2,3,4- 2-3> bis [1- (6, N-dimethyl-1,2,3,4- 테트라히드로퀴놀린Tetrahydroquinoline -8-일)-2,3,4,5-테-8-day) -2,3,4,5-te 트라메틸시클로펜Tramethylcyclophene 타디에닐] 티타늄(Tadienyl] Titanium ( lVlV ) 디메틸 화합물Dimethyl compound
상기에서 제조한 리튬염 화합물(리튬 1-(N-메틸l-1,2,3,4-테트라히드로퀴놀린-8-일)-2,3,4,5-테트라메틸시클로펜타디에닐)을 사용하여 상기 실시예 1과 같은 방법으로 제조하였다.Lithium salt compound prepared above (lithium 1- (N-methyll-1,2,3,4-tetrahydroquinolin-8-yl) -2,3,4,5-tetramethylcyclopentadienyl) It was prepared in the same manner as in Example 1 above.
1H NMR(C6D6) : δ 6.65(m, 4H, CH), δ 2.83(m, 4H, quin-CH2), δ 2.54(t, J=7.2Hz, 4H, quin-CH2), δ 2.28(s, 6H, N-CH3), δ 2.14(s, 6H, Ph-CH3), δ 1.99(s, 12H, Cp-CH3), δ 1.87(s, 12H, Cp-CH3), δ 1.52(m, 4H, quin-CH2), δ 1.28(s, 6H, Ti-CH3) ppm. 1 H NMR (C 6 D 6 ): δ 6.65 (m, 4H, CH), δ 2.83 (m, 4H, quin-CH 2 ), δ 2.54 (t, J = 7.2Hz, 4H, quin-CH 2 ) , δ 2.28 (s, 6H, N-CH 3 ), δ 2.14 (s, 6H, Ph-CH 3 ), δ 1.99 (s, 12H, Cp-CH 3 ), δ 1.87 (s, 12H, Cp-CH 3 ), δ 1.52 (m, 4H, quin-CH 2 ), δ 1.28 (s, 6H, Ti-CH 3 ) ppm.
본 발명은 헤테로 원자를 포함하는 사이클로펜타다이에닐 리간드가 배위된 새로운 전이금속 화합물로서, 본 발명에 따른 전이금속 화합물은 반응성이 높은 촉매 조성물의 제조에 제공될 수 있다.The present invention is a novel transition metal compound coordinated with a cyclopentadienyl ligand comprising a hetero atom, and the transition metal compound according to the present invention can be provided for the preparation of a highly reactive catalyst composition.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070042084A KR100988055B1 (en) | 2007-04-30 | 2007-04-30 | New fourth group transition metal compounds having hetero atom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070042084A KR100988055B1 (en) | 2007-04-30 | 2007-04-30 | New fourth group transition metal compounds having hetero atom |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080097019A true KR20080097019A (en) | 2008-11-04 |
KR100988055B1 KR100988055B1 (en) | 2010-10-18 |
Family
ID=40285078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070042084A KR100988055B1 (en) | 2007-04-30 | 2007-04-30 | New fourth group transition metal compounds having hetero atom |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100988055B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015046930A1 (en) * | 2013-09-26 | 2015-04-02 | 주식회사 엘지화학 | Catalytic composition and method for preparing polymer including same |
US9376519B2 (en) | 2013-09-26 | 2016-06-28 | Lg Chem, Ltd. | Transition metal compound, catalytic composition including the same, and method for preparing polymer using the same |
US9550848B2 (en) | 2013-09-26 | 2017-01-24 | Lg Chem, Ltd. | Method of preparing olefin-based polymer and olefin-based polymer prepared thereby |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19915108A1 (en) * | 1999-04-01 | 2000-10-05 | Bayer Ag | Supported catalysts with a donor-acceptor interaction |
ITMI20022052A1 (en) | 2002-09-27 | 2004-03-28 | Polimeri Europa Spa | STABILIZED METALLOCENIC COMPOUNDS OF GROUP 4 TRANSITION METALS AND PROCESS FOR THEIR PREPARATION. |
KR100999592B1 (en) * | 2007-02-15 | 2010-12-08 | 주식회사 엘지화학 | New fourth group transition metal compounds having cyclopentadienyl ligand, method for preparing the compounds and method for preparing olefin polymer using the compounds |
-
2007
- 2007-04-30 KR KR1020070042084A patent/KR100988055B1/en active IP Right Grant
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015046930A1 (en) * | 2013-09-26 | 2015-04-02 | 주식회사 엘지화학 | Catalytic composition and method for preparing polymer including same |
US9376519B2 (en) | 2013-09-26 | 2016-06-28 | Lg Chem, Ltd. | Transition metal compound, catalytic composition including the same, and method for preparing polymer using the same |
US9550848B2 (en) | 2013-09-26 | 2017-01-24 | Lg Chem, Ltd. | Method of preparing olefin-based polymer and olefin-based polymer prepared thereby |
US9683061B2 (en) | 2013-09-26 | 2017-06-20 | Lg Chem, Ltd. | Catalyst composition and method of preparing polymer including the same |
Also Published As
Publication number | Publication date |
---|---|
KR100988055B1 (en) | 2010-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100999592B1 (en) | New fourth group transition metal compounds having cyclopentadienyl ligand, method for preparing the compounds and method for preparing olefin polymer using the compounds | |
AU601654B2 (en) | Process for the preparation of a chiral stereorigic metallocene compound | |
EP2625182B1 (en) | Stereoselective synthesis of bridged metallocene complexes | |
JP2010514836A (en) | Method for producing transition metal complex, transition metal complex produced by the method, and catalyst composition containing the transition metal complex | |
JP3986441B2 (en) | Method for producing monohalide or dihalide metallocene compound | |
KR100988055B1 (en) | New fourth group transition metal compounds having hetero atom | |
JP3815814B2 (en) | Method for producing bridged metallocene compounds | |
EP0856518B1 (en) | Metallocene compounds, synthesis process and use thereof | |
JPH07252263A (en) | Crosslinked cyclopentandienylmagnesium compound, its preparation and preparation of metallocene | |
US6774253B1 (en) | Process for the preparation of titanium complexes | |
RU2337104C2 (en) | METHOD FOR RACEMIC DIORGANOSILYL-BIS-(2-METHYLBENZO-[e]INDENYL)ZIRCONIUM COMPOUNDS DIASTEREOSELECTIVE SYNTHESIS, AND RACEMIC COMPOUND OF TRANSITION METAL | |
Rufanov et al. | Polyelement substituted cyclopentadienes and indenes—Novel ligand precursors for organotransition metal chemistry | |
Lee et al. | Synthesis of bis (1, 2, 3-substituted cyclopentadienyl) zirconium dichloride derivatives and their use in ethylene polymerization | |
US6087518A (en) | Silylated and N-silylated compound synthesis | |
US5892077A (en) | Process for modifying the rac/meso ratio in a metallocene compound | |
US5859276A (en) | Organotransition metal compounds | |
EP0926150B1 (en) | Production of alkali metal cyclopentadienylides and production of dihalobis(eta-substituted-cyclopentadienyl) zirconium from alkali metal cyclopentadienylides | |
JP3740180B2 (en) | Method for producing biscyclopentadienyl compound | |
Fierro et al. | Synthesis and characterization of new one-carbon-bridged titanocene and zirconocene derivatives | |
KR101077272B1 (en) | Method for preparing transition metal complexes | |
KR101025039B1 (en) | Novel cyclopentadienyl ligand and fourth group transition metal compound having the same | |
EP1046642B1 (en) | Process for preparation of silyl-bridged fluorenyl-cyclopentadienyl ligands and silyl-bridged fluorenyl-cyclopentadienyl metallocenes | |
JP3713405B2 (en) | Method for producing bridged zirconocene compound | |
KR20040024059A (en) | A method for producing dinuclear transition metal complexes as olefin polymerization catalyst | |
US6927262B2 (en) | Bridged biphospholes and metallocenes prepared therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130930 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140924 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150923 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160928 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170919 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181002 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20191001 Year of fee payment: 10 |